Skip to content
エタゾラート

Structure via PubChem · Public domain (PubChem)

EntityQ5402458· pop 6· linked from 934 articles

エタゾラート

Sign in to save

Also known as EHT-0202, SQ 20009

Etazolate (SQ-20,009, EHT-0202) is an anxiolytic drug which is a pyrazolopyridine derivative and has unique pharmacological properties. It acts as a positive allosteric modulator of the GABAA receptor at the barbiturate binding site, as an adenosine antagonist of the A1 and A2 subtypes, and as a phosphodiesterase inhibitor selective for the PDE4 isoform. It is currently in clinical trials for the treatment of Alzheimer's disease.

Chemical data

Formula
C14H19N5O2
Molecular weight
289.33 g/mol
IUPAC name
ethyl 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)pyrazolo[3,4-b]pyridine-5-carboxylate
SMILES
CCN1C2=NC=C(C(=C2C=N1)NN=C(C)C)C(=O)OCC
InChIKey
OPQRBXUBWHDHPQ-UHFFFAOYSA-N
XLogP
2.1
Polar surface area
81.4 Ų
H-bond donors
1
H-bond acceptors
6
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
Alzheimer disease

via ChEMBL · EBI

Wikidata facts

Mass
289.153875
Show 4 more facts
chemical formula
C₁₄H₁₉N₅O₂
canonical SMILES
CCN1C2=NC=C(C(=C2C=N1)NN=C(C)C)C(=O)OCC
Commons category
Etazolate
Sources (2)

via Wikidata · CC0

Available in 5 languages

via Wikidata sitelinks · CC0